About Mosaic Biosciences
Mosaic Biosciences is a company based in Boulder (United States) founded in 2009. Mosaic Biosciences has raised $14.7 million across 4 funding rounds from investors including Colorado Office of Economic Development and International Trade, Telegraph Hill Partners and Morgenthaler. Mosaic Biosciences offers products and services including Antibody Therapeutics Platform and Protein Therapeutics Service. Mosaic Biosciences operates in a competitive market with competitors including Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others.
- Headquarter Boulder, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mosaic Biosciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.7 M (USD)
in 4 rounds
-
Latest Funding Round
$11.4 M (USD), Series B
Jun 14, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mosaic Biosciences
Mosaic Biosciences offers a comprehensive portfolio of products and services, including Antibody Therapeutics Platform and Protein Therapeutics Service.
Accelerates discovery and optimization of therapeutic antibodies.
Designs and characterizes novel proteins for preclinical candidates.
People of Mosaic Biosciences
Unlock access to complete
Funding Insights of Mosaic Biosciences
Mosaic Biosciences has successfully raised a total of $14.7M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $11.4 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mosaic Biosciences
Mosaic Biosciences has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Colorado Office of Economic Development and International Trade, Telegraph Hill Partners and Morgenthaler.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Locked | Locked | Locked | |
|
Venture capital and private equity investment firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Mosaic Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mosaic Biosciences
Investment portfolio details for Mosaic Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mosaic Biosciences
Detailed financials for Mosaic Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mosaic Biosciences Comparisons
Peer comparison for Mosaic Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mosaic Biosciences
Mosaic Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| Locked | Locked | Locked |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| Locked | Locked | Locked |
Noninvasive devices and biologics for wound healing are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for infectious disease
|
Detailed competitors of Mosaic Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mosaic Biosciences
Complete news archive for Mosaic Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mosaic Biosciences
Mosaic Biosciences was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Mosaic Biosciences is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Marty Stanton is the current CEO of Mosaic Biosciences.
Mosaic Biosciences is a funded company, having raised a total of $14.7M across 4 funding rounds to date.
Mosaic Biosciences was founded in 2009 in Boulder, United States, focusing on biotechnology for tissue regeneration. Proprietary technology is utilized to create synthetic extracellular matrices and three-dimensional scaffolds. These materials are engineered with biophysical and biochemical properties to aid applications such as wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers. Operations center on advancing this platform for medical uses.
Mosaic Biosciences's top competitors include Ilya Pharma, SanuWave and QBiotics.
Mosaic Biosciences offers Antibody Therapeutics Platform and Protein Therapeutics Service.
Mosaic Biosciences has 5 investors. Key investors include Colorado Office of Economic Development and International Trade, Telegraph Hill Partners, Morgenthaler, Healthcare Ventures, and High Country Ventures.